These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9721237)

  • 1. Acylation of the influenza hemagglutinin modulates fusion activity.
    Fischer C; Schroth-Diez B; Herrmann A; Garten W; Klenk HD
    Virology; 1998 Sep; 248(2):284-94. PubMed ID: 9721237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores.
    Melikyan GB; Jin H; Lamb RA; Cohen FS
    Virology; 1997 Aug; 235(1):118-28. PubMed ID: 9300043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of acylation sites of influenza B virus hemagglutinin on fusion pore formation and dilation.
    Ujike M; Nakajima K; Nobusawa E
    J Virol; 2004 Nov; 78(21):11536-43. PubMed ID: 15479794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain-structure of cytoplasmic border region is main determinant for palmitoylation of influenza virus hemagglutinin (H7).
    Ponimaskin E; Schmidt MF
    Virology; 1998 Sep; 249(2):325-35. PubMed ID: 9791024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylation-mediated membrane anchoring of avian influenza virus hemagglutinin is essential for fusion pore formation and virus infectivity.
    Wagner R; Herwig A; Azzouz N; Klenk HD
    J Virol; 2005 May; 79(10):6449-58. PubMed ID: 15858028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment.
    Philipp HC; Schroth B; Veit M; Krumbiegel M; Herrmann A; Schmidt MF
    Virology; 1995 Jun; 210(1):20-8. PubMed ID: 7793071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.
    Cross KJ; Wharton SA; Skehel JJ; Wiley DC; Steinhauer DA
    EMBO J; 2001 Aug; 20(16):4432-42. PubMed ID: 11500371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylation Contributes to Membrane Curvature in Influenza A Virus Assembly and Hemagglutinin-Mediated Membrane Fusion.
    Chlanda P; Mekhedov E; Waters H; Sodt A; Schwartz C; Nair V; Blank PS; Zimmerberg J
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation.
    Sakai T; Ohuchi R; Ohuchi M
    J Virol; 2002 May; 76(9):4603-11. PubMed ID: 11932425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
    Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
    Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of a point mutation in H5N1 avian influenza virus hemagglutinin in relation to virus entry into live mammalian cells.
    Su Y; Yang HY; Zhang BJ; Jia HL; Tien P
    Arch Virol; 2008; 153(12):2253-61. PubMed ID: 19020946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
    Kozerski C; Ponimaskin E; Schroth-Diez B; Schmidt MF; Herrmann A
    J Virol; 2000 Aug; 74(16):7529-37. PubMed ID: 10906206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elongation of the cytoplasmic tail interferes with the fusion activity of influenza virus hemagglutinin.
    Ohuchi M; Fischer C; Ohuchi R; Herwig A; Klenk HD
    J Virol; 1998 May; 72(5):3554-9. PubMed ID: 9557635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity.
    Korte T; Epand RF; Epand RM; Blumenthal R
    Virology; 2001 Oct; 289(2):353-61. PubMed ID: 11689057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly.
    Chen BJ; Takeda M; Lamb RA
    J Virol; 2005 Nov; 79(21):13673-84. PubMed ID: 16227287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin.
    Schroth-Diez B; Ponimaskin E; Reverey H; Schmidt MF; Herrmann A
    J Virol; 1998 Jan; 72(1):133-41. PubMed ID: 9420208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-anchored incorporation of a foreign protein in recombinant influenza virions.
    Zhou Y; König M; Hobom G; Neumeier E
    Virology; 1998 Jun; 246(1):83-94. PubMed ID: 9656996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane fusion by surrogate receptor-bound influenza haemagglutinin.
    Millar BM; Calder LJ; Skehel JJ; Wiley DC
    Virology; 1999 May; 257(2):415-23. PubMed ID: 10329552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.